9987.T Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 mai 2024 @ 08:15):

Stats
Dagens volum	440 100
Gjennomsnittsvolum	284 606
Markedsverdi	294.98B
EPS	¥0 ( 2024-02-08 )
Neste inntjeningsdato	( ¥83.23 ) 2024-05-13
Last Dividend	¥36.00 ( 2023-03-30 )
Next Dividend	¥0 ( N/A )
P/E	14.00
ATR14	¥2.58 (0.05%)

Volum Korrelasjon

Lang: 0.04 (neutral)

Kort: 0.65 (weak)

Signal:(44.766) Neutral

Suzuken Co., Ltd. Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Suzuken Co., Ltd. Korrelasjon - Valuta/Råvare

0.62
( weak )

0.82
( strong )

0.63
( weak )

-0.54
( weak negative )

0.20
( neutral )

Suzuken Co., Ltd. Økonomi

Annual	2022
Omsetning:	¥2 314.83B
Bruttogevinst:	¥179.70B (7.76 %)
EPS:	¥236.46

FY	2022
Omsetning:	¥2 314.83B
Bruttogevinst:	¥179.70B (7.76 %)
EPS:	¥236.46

FY	2022
Omsetning:	¥2 232.77B
Bruttogevinst:	¥160.99B (7.21 %)
EPS:	¥163.19

FY	2021
Omsetning:	¥2 128.48B
Bruttogevinst:	¥157.84B (7.42 %)
EPS:	¥88.52

Financial Reports:

No articles found.

Suzuken Co., Ltd. Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥36.00 (N/A)	¥0 (N/A)	¥36.00 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

Suzuken Co., Ltd. Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 6.61 - average (87.08%) | Divividend Growth Potential Score: 2.58 - Decrease likely (48.44%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	¥9.09	2001-03-27
Last Dividend	¥36.00	2023-03-30
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	46	--
Total Paid Out	¥939.27	--
Avg. Dividend % Per Year	0.00%	--
Score	2.84	--
Div. Sustainability Score	6.61
Div.Growth Potential Score	2.58
Div. Directional Score	4.59	--

Next Divdend (Est)
(2024-07-03)

¥0 Estimate 1.26 %

Dividend Stability

0.10 Bad

Dividend Score

2.84

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
7987.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
7222.T	Ex Dividend Junior	2023-09-28	Semi-Annually	0.00%
6462.T	Ex Dividend Junior	2023-09-28	Semi-Annually	0.00%
5482.T	Ex Dividend Knight	2023-09-28	Annually	0.00%
4471.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
3657.T	Ex Dividend Junior	2024-01-30	Annually	0.00%
2910.T	Ex Dividend Knight	2023-10-30	Semi-Annually	0.00%
1721.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
9766.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
8850.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0117	1.500	9.77	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0212	1.200	9.29	10.00	[0 - 0.3]
returnOnEquityTTM	0.0664	1.500	-0.373	-0.560	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.186	0.800	9.07	7.26	[1 - 3]
quickRatioTTM	0.954	0.800	9.10	7.28	[0.8 - 2.5]
cashRatioTTM	0.206	1.500	9.97	10.00	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	807.19	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	212.65	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	212.65	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.0775	1.000	-2.04	-2.04	[0.2 - 0.8]
operatingProfitMarginTTM	0.0146	1.000	-1.707	-1.707	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	1.818	0.800	1.213	0.970	[0.5 - 2]
Total Score				6.61

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	13.91	1.000	8.70	0	[1 - 100]
returnOnEquityTTM	0.0664	2.50	-0.240	-0.560	[0.1 - 1.5]
freeCashFlowPerShareTTM	212.65	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	1.684	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	212.65	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-3.60	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.00727	1.000	-2.32	0	[0.1 - 0.5]
Total Score				2.58

Suzuken Co., Ltd.

Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the wholesale of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution Business, Pharmaceutical Manufacturing Business, Pharmacy Business, and Healthcare-Related Services Business. The Pharmaceutical Distribution Business segment procures ethical drugs, diagnostic reagents, medical equipment and supplies, and other health-related items from manufacturers and supplies to medical institutions and pharmacies. The Pharmaceutical Manufacturing Business segment engages in the research and development, manufacturing, and marketing of ethical pharmaceuticals and diagnostic products focusing on the areas of diabetes and kidney diseases. The Pharmacy Business segment provides services through family pharmacists, as well as improves the operations of local pharmacies and provides educational support. The Healthcare-Related Services Business segment provides manufacturer support services, such as contract distribution for manufacturers; distribution of orphan drugs; and nursing care services, as well as develops, manufactures, and sells electrocardiographs, sphygmomanometers, stethoscopes, medical materials, and health promotion equipment. Suzuken Co., Ltd. also publishes medical magazines for medical institutions. The company has collaboration with Bushu Pharmaceuticals Ltd. provide contract specialty drug services. Suzuken Co., Ltd. was founded in 1932 and is headquartered in Nagoya, Japan.